Holen Sie sich die Stockscreener-App
182.70
1.07%
1.93
Handel nachbörslich:
182.83
0.13
+0.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVDA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$180.77
Offen:
$181.55
24-Stunden-Volumen:
122.52M
Relative Volume:
0.66
Marktkapitalisierung:
$4.46T
Einnahmen:
$148.52B
Nettoeinkommen (Verlust:
$76.77B
KGV:
58.94
EPS:
3.1
Netto-Cashflow:
$72.06B
1W Leistung:
+5.17%
1M Leistung:
+14.19%
6M Leistung:
+40.71%
1J Leistung:
+74.05%
1-Tages-Spanne:
$180.40
$183.30
1-Wochen-Bereich:
$174.52
$183.88
52-Wochen-Spanne:
$86.62
$183.88
Nvidia Corp Stock (NVDA) Company Profile
Firmenname
Nvidia Corp
Sektor
Branche
Telefon
408-486-2000
Adresse
2788 SAN TOMAS EXPRESSWAY, SANTA CLARA, CA
Vergleichen Sie NVDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVDA
Nvidia Corp
|
182.70 | 4.38T | 148.52B | 76.77B | 72.06B | 3.10 |
|
AVGO
Broadcom Inc
|
304.97 | 1.42T | 57.05B | 12.92B | 22.70B | 2.67 |
|
TSM
Taiwan Semiconductor Manufacturing Adr
|
241.83 | 1.20T | 106.27B | 45.12B | 27.68B | 8.7035 |
|
AMD
Advanced Micro Devices Inc
|
172.76 | 264.72B | 29.60B | 2.83B | 4.04B | 1.74 |
|
TXN
Texas Instruments Inc
|
187.22 | 169.02B | 16.68B | 5.04B | 1.50B | 5.46 |
Nvidia Corp Stock (NVDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-16 | Bestätigt | Needham | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-06-25 | Bestätigt | Loop Capital | Buy |
| 2025-05-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2025-05-29 | Bestätigt | TD Cowen | Buy |
| 2025-04-30 | Eingeleitet | Seaport Research Partners | Sell |
| 2025-04-16 | Bestätigt | BofA Securities | Buy |
| 2025-04-16 | Bestätigt | Raymond James | Strong Buy |
| 2025-04-03 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-27 | Herabstufung | Summit Insights | Buy → Hold |
| 2024-11-21 | Bestätigt | Barclays | Overweight |
| 2024-11-21 | Bestätigt | Evercore ISI | Outperform |
| 2024-11-21 | Bestätigt | Goldman | Buy |
| 2024-11-21 | Bestätigt | JP Morgan | Overweight |
| 2024-11-21 | Bestätigt | Needham | Buy |
| 2024-11-21 | Bestätigt | Robert W. Baird | Outperform |
| 2024-11-21 | Bestätigt | TD Cowen | Buy |
| 2024-11-21 | Bestätigt | The Benchmark Company | Buy |
| 2024-11-21 | Bestätigt | Truist | Buy |
| 2024-11-21 | Bestätigt | Wells Fargo | Overweight |
| 2024-11-14 | Bestätigt | Oppenheimer | Outperform |
| 2024-11-12 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-18 | Bestätigt | BofA Securities | Buy |
| 2024-10-11 | Bestätigt | Goldman | Buy |
| 2024-09-18 | Eingeleitet | William Blair | Outperform |
| 2024-08-29 | Bestätigt | Needham | Buy |
| 2024-08-19 | Bestätigt | Goldman | Buy |
| 2024-08-06 | Hochstufung | New Street | Neutral → Buy |
| 2024-07-15 | Bestätigt | TD Cowen | Buy |
| 2024-07-12 | Bestätigt | The Benchmark Company | Buy |
| 2024-07-09 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-07-08 | Bestätigt | UBS | Buy |
| 2024-07-05 | Herabstufung | New Street | Buy → Neutral |
| 2024-07-01 | Bestätigt | Morgan Stanley | Overweight |
| 2024-06-18 | Bestätigt | Rosenblatt | Buy |
| 2024-06-03 | Bestätigt | BofA Securities | Buy |
| 2024-05-24 | Herabstufung | DZ Bank | Buy → Hold |
| 2024-05-23 | Bestätigt | Craig Hallum | Buy |
| 2024-05-23 | Bestätigt | Deutsche Bank | Hold |
| 2024-05-23 | Bestätigt | Evercore ISI | Outperform |
| 2024-05-23 | Bestätigt | Goldman | Buy |
| 2024-05-23 | Bestätigt | JP Morgan | Overweight |
| 2024-05-23 | Bestätigt | Jefferies | Buy |
| 2024-05-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-05-23 | Bestätigt | Mizuho | Buy |
| 2024-05-23 | Bestätigt | Morgan Stanley | Overweight |
| 2024-05-23 | Bestätigt | Needham | Buy |
| 2024-05-23 | Bestätigt | Piper Sandler | Overweight |
| 2024-05-23 | Bestätigt | Raymond James | Strong Buy |
| 2024-05-23 | Bestätigt | Stifel | Buy |
| 2024-05-23 | Bestätigt | Susquehanna | Positive |
| 2024-05-23 | Bestätigt | TD Cowen | Buy |
| 2024-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2024-05-23 | Bestätigt | Truist | Buy |
| 2024-05-23 | Bestätigt | UBS | Buy |
| 2024-05-23 | Bestätigt | Wells Fargo | Overweight |
| 2024-05-23 | Bestätigt | Wolfe Research | Outperform |
| 2024-05-20 | Bestätigt | Barclays | Overweight |
| 2024-05-20 | Bestätigt | Robert W. Baird | Outperform |
| 2024-05-20 | Bestätigt | Stifel | Buy |
| 2024-05-20 | Bestätigt | Susquehanna | Positive |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Bestätigt | Raymond James | Strong Buy |
| 2024-04-10 | Bestätigt | Morgan Stanley | Overweight |
| 2024-04-08 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-03-22 | Bestätigt | UBS | Buy |
| 2024-03-21 | Bestätigt | TD Cowen | Outperform |
| 2024-03-07 | Bestätigt | Mizuho | Buy |
| 2024-02-22 | Bestätigt | BofA Securities | Buy |
| 2024-02-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-02-22 | Bestätigt | Citigroup | Buy |
| 2024-02-22 | Bestätigt | DA Davidson | Neutral |
| 2024-02-22 | Bestätigt | Deutsche Bank | Hold |
| 2024-02-22 | Bestätigt | Goldman | Buy |
| 2024-02-22 | Bestätigt | HSBC Securities | Buy |
| 2024-02-22 | Bestätigt | JP Morgan | Overweight |
| 2024-02-22 | Bestätigt | Jefferies | Buy |
| 2024-02-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-22 | Bestätigt | Mizuho | Buy |
| 2024-02-22 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-22 | Bestätigt | Needham | Buy |
| 2024-02-22 | Bestätigt | Stifel | Buy |
| 2024-02-22 | Bestätigt | TD Cowen | Outperform |
| 2024-02-22 | Bestätigt | The Benchmark Company | Buy |
| 2024-02-22 | Bestätigt | Truist | Buy |
| 2024-02-22 | Bestätigt | UBS | Buy |
| 2024-02-22 | Bestätigt | Wedbush | Outperform |
| 2024-02-22 | Bestätigt | Wolfe Research | Outperform |
| 2024-02-16 | Eingeleitet | Loop Capital | Buy |
| 2024-02-15 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-13 | Bestätigt | UBS | Buy |
| 2024-02-05 | Bestätigt | Goldman | Buy |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-01-03 | Eingeleitet | DA Davidson | Neutral |
| 2023-11-22 | Bestätigt | BMO Capital Markets | Outperform |
| 2023-11-22 | Bestätigt | Bernstein | Outperform |
| 2023-11-22 | Bestätigt | BofA Securities | Buy |
| 2023-11-22 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-11-22 | Bestätigt | Goldman | Buy |
| 2023-11-22 | Bestätigt | JP Morgan | Overweight |
| 2023-11-22 | Bestätigt | Mizuho | Buy |
| 2023-11-22 | Bestätigt | Morgan Stanley | Overweight |
| 2023-11-22 | Bestätigt | Rosenblatt | Buy |
| 2023-11-22 | Bestätigt | Truist | Buy |
| 2023-11-22 | Bestätigt | UBS | Buy |
| 2023-11-22 | Bestätigt | Wells Fargo | Overweight |
| 2023-10-11 | Bestätigt | TD Cowen | Outperform |
| 2023-08-24 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2023-08-24 | Bestätigt | Rosenblatt | Buy |
| 2023-08-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-08-24 | Bestätigt | TD Cowen | Outperform |
| 2023-08-21 | Bestätigt | HSBC Securities | Buy |
| 2023-08-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2023-08-09 | Bestätigt | Stifel | Hold |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-20 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-17 | Bestätigt | Citigroup | Buy |
| 2023-07-14 | Bestätigt | Truist | Buy |
| 2023-07-11 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2023-06-30 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2023-06-16 | Bestätigt | Morgan Stanley | Overweight |
| 2023-05-25 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-05-25 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-05-25 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-18 | Hochstufung | HSBC Securities | Reduce → Buy |
| 2023-03-27 | Bestätigt | UBS | Buy |
| 2023-03-21 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2023-03-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-03-02 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-02-23 | Hochstufung | Goldman | Neutral → Buy |
| 2023-02-21 | Bestätigt | BMO Capital Markets | Outperform |
| 2023-02-16 | Herabstufung | DZ Bank | Buy → Sell |
| 2023-01-23 | Bestätigt | Truist | Buy |
| 2022-12-19 | Bestätigt | Needham | Buy |
| 2022-12-15 | Eingeleitet | HSBC Securities | Reduce |
| 2022-11-17 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-11-16 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-09-08 | Eingeleitet | Stifel | Hold |
| 2022-09-02 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2022-08-08 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-07-13 | Bestätigt | Susquehanna | Positive |
| 2022-05-26 | Fortgesetzt | The Benchmark Company | Buy |
| 2022-05-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Hochstufung | New Street | Neutral → Buy |
| 2022-04-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-03-15 | Bestätigt | Cowen | Outperform |
| 2022-03-07 | Fortgesetzt | Goldman | Neutral |
| 2022-02-17 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-11-18 | Bestätigt | BofA Securities | Buy |
| 2021-11-18 | Bestätigt | Craig Hallum | Buy |
| 2021-11-18 | Bestätigt | Deutsche Bank | Hold |
| 2021-11-18 | Bestätigt | JP Morgan | Overweight |
| 2021-11-18 | Bestätigt | Jefferies | Buy |
| 2021-11-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-11-18 | Bestätigt | Mizuho | Buy |
| 2021-11-18 | Bestätigt | Needham | Buy |
| 2021-11-18 | Bestätigt | Piper Sandler | Overweight |
| 2021-11-18 | Bestätigt | Raymond James | Strong Buy |
| 2021-11-18 | Bestätigt | Truist | Buy |
| 2021-11-15 | Bestätigt | Citigroup | Buy |
| 2021-11-15 | Bestätigt | UBS | Buy |
| 2021-11-12 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Summit Insights | Sell → Buy |
| 2021-10-05 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-09-17 | Bestätigt | BofA Securities | Buy |
| 2021-08-20 | Fortgesetzt | The Benchmark Company | Buy |
| 2021-08-19 | Herabstufung | Summit Insights | Hold → Sell |
| 2021-08-12 | Bestätigt | Evercore ISI | Outperform |
| 2021-08-12 | Bestätigt | UBS | Buy |
| 2021-08-12 | Bestätigt | Wells Fargo | Overweight |
| 2021-08-04 | Bestätigt | Rosenblatt | Buy |
| 2021-07-15 | Bestätigt | Mizuho | Buy |
| 2021-07-08 | Bestätigt | Oppenheimer | Outperform |
| 2021-07-06 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-07-01 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-06-22 | Bestätigt | Raymond James | Strong Buy |
| 2021-06-18 | Bestätigt | BofA Securities | Buy |
| 2021-06-17 | Bestätigt | Jefferies | Buy |
| 2021-05-27 | Bestätigt | BofA Securities | Buy |
| 2021-05-27 | Bestätigt | Cowen | Outperform |
| 2021-05-27 | Hochstufung | Craig Hallum | Hold → Buy |
| 2021-05-20 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2021-05-05 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-04-15 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-04-13 | Bestätigt | Cowen | Outperform |
| 2021-04-13 | Bestätigt | Rosenblatt | Buy |
| 2021-02-25 | Bestätigt | Cowen | Outperform |
| 2021-02-22 | Bestätigt | Susquehanna | Positive |
| 2021-02-03 | Hochstufung | New Street | Sell → Neutral |
| 2020-11-12 | Bestätigt | Cascend Securities | Buy |
| 2020-10-09 | Herabstufung | New Street | Neutral → Sell |
| 2020-10-06 | Bestätigt | BMO Capital Markets | Outperform |
| 2020-10-02 | Bestätigt | Wedbush | Outperform |
| 2020-09-15 | Bestätigt | Needham | Buy |
| 2020-09-02 | Bestätigt | BofA Securities | Buy |
| 2020-09-02 | Bestätigt | Credit Suisse | Outperform |
| 2020-09-02 | Bestätigt | Goldman | Buy |
| 2020-09-02 | Bestätigt | Mizuho | Buy |
| 2020-09-02 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-09-02 | Bestätigt | The Benchmark Company | Buy |
| 2020-08-20 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2020-08-20 | Bestätigt | Needham | Buy |
| 2020-08-20 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-08-20 | Bestätigt | Raymond James | Outperform |
| 2020-08-20 | Bestätigt | Rosenblatt | Buy |
| 2020-08-20 | Bestätigt | Susquehanna | Positive |
| 2020-08-20 | Bestätigt | Truist | Buy |
| 2020-08-20 | Bestätigt | Wedbush | Outperform |
| 2020-08-20 | Bestätigt | Wells Fargo | Overweight |
Alle ansehen
Nvidia Corp Aktie (NVDA) Neueste Nachrichten
AI juggernaut Nvidia stalks Firmus’ pre-IPO round - AFR
Nvidia, AMD agree to pay U.S. government 15% of A.I. chip sales to China - The Washington Post
Insider Selling: NVIDIA Corporation (NASDAQ:NVDA) CEO Sells 75,000 Shares of Stock - MarketBeat
Nvidia, AMD Agree to Pay US 15% of China Chip Sale Revenue - Bloomberg.com
U.S. government imposes fee on Nvidia, AMD exports to China - Axios
Nvidia to Pay US 15% of China Chip Sale Revenue - Yahoo Finance
Nvidia, AMD to pay 15% of China chip sale revenues to US, official says - Reuters
Goldman Sachs Sets the Bar for Nvidia Stock Ahead of Earnings - TipRanks
U.S. Government to Take Cut of Nvidia and AMD A.I. Chip Sales to China - The New York Times
Nvidia and AMD reportedly agree to pay 15% of China chip sale revenues to US - The Guardian
Here Are My Top "Magnificent Seven" Stocks to Buy Now - The Motley Fool
Nvidia, AMD agree to pay US 15% of China chip sale revenue - Fortune
Nvidia and AMD to pay U.S. 15% of China chip revenue, says report - The Japan Times
Nvidia and AMD to pay 15% of China chip sales revenues to the U.S. government, FT reports - CNBC
Nvidia and AMD reportedly will give U.S. government 15% of their China chip revenues - MarketWatch
China Flags Security Risks in Nvidia H20 Chips, Threatening China Sales - TipRanks
FirstFT: Nvidia and AMD to pay portion of China chip sale revenues to US government - Financial Times
Nvidia, AMD to pay 15% of China chip sale revenues to US, FT reports - Reuters
Nvidia, AMD to Pay 15% of China Chip Sale Income to US, FT Says - MSN
Nvidia and AMD to pay 15% of China chip sale revenues to US government, FT reports - Yahoo Finance
Nvidia and AMD to pay 15% of China chip sale revenues to US government - Financial Times
Nvidia claps back against Chinese accusations its H20 chips pose a security risk - CNBC
Lessons from Jensen Huang: What entrepreneurs can learn from Nvidia’s meteoric rise - The Times of India
Up 72% in a year! Too late to snap up Nvidia stock? - uk.finance.yahoo.com
China insists Nvidia’s H20 chips are unsafe, not advanced, and environmentally unfriendly - Cryptopolitan
Nvidia's ‘most underappreciated’ business is taking off like a 'rocket ship' - Yahoo Finance
Where Will Nvidia Be in 5 Years? - Nasdaq
Which Is the Better Choice for Investing $10,000 Right Now: Nvidia or XRP (Ripple)? - Nasdaq
Bleakley Financial Group LLC Acquires 2,606 Shares of NVIDIA Corporation (NASDAQ:NVDA) - MarketBeat
NVIDIA Corporation (NASDAQ:NVDA) Stock Holdings Increased by Slow Capital Inc. - MarketBeat
UNICOM Systems Inc. Has $82.05 Million Stake in NVIDIA Corporation (NASDAQ:NVDA) - MarketBeat
NVIDIA Corporation (NASDAQ:NVDA) is Zullo Investment Group Inc.'s 2nd Largest Position - MarketBeat
Peregrine Investment Management Inc. Takes $8.13 Million Position in NVIDIA Corporation (NASDAQ:NVDA) - MarketBeat
NVIDIA Corporation (NASDAQ:NVDA) Position Lowered by Securian Asset Management Inc. - MarketBeat
NVIDIA Corporation (NASDAQ:NVDA) Stake Lessened by Left Brain Wealth Management LLC - MarketBeat
Cutter & CO Brokerage Inc. Sells 2,254 Shares of NVIDIA Corporation (NASDAQ:NVDA) - MarketBeat
Nvidia created history by becoming the first company in the world to earn $ 4 trillion - Insurance Khabar
Chinese state media says Nvidia H20 chips not safe for China - Reuters
Davis Selected Advisers Increases Stake in Nvidia Corporation - TipRanks
Nvidia CEO Jensen Huang checks salaries of company's entire 42,000 employees; says: It's a strategy that - The Times of India
US licenses Nvidia to export chips to China - The Express Tribune
Where Will Nvidia Stock Be in 1 Year? - AOL.com
Nvidia now makes up 8% of S&P 500, highest share for any stock since 1981 - Cryptopolitan
AI disruption hits markets sooner than expected - Cryptopolitan
Nvidia reportedly starts getting U.S. licenses to export H20 chips to China (NVDA:NASDAQ) - Seeking Alpha
Goldman Sachs Reiterates Buy on NVIDIA (NVDA) With $200 PT Ahead of Earnings - Yahoo Finance
NVIDIA Corporation ($NVDA) Stock: U.S. Grants H20 Chip Export Licenses to China After CEO’s White House Meeting - CoinCentral
If You'd Invested $10,000 in Nvidia Stock 5 Years Ago, Here's How Much You'd Have Today - The Motley Fool
Traders are fleeing stocks feared to be under threat from AI - Yahoo Finance
Microsoft, Apple, Amazon, and Meta Just Gave Nvidia Investors Great News - Yahoo Finance
Nvidia Secures Licenses to Export H20 Chips to China. Will this Drive NVDA Stock Higher? - TipRanks
Finanzdaten der Nvidia Corp-Aktie (NVDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):